DE602004023620D1 - Inhibitoren von cathepsin s - Google Patents

Inhibitoren von cathepsin s

Info

Publication number
DE602004023620D1
DE602004023620D1 DE602004023620T DE602004023620T DE602004023620D1 DE 602004023620 D1 DE602004023620 D1 DE 602004023620D1 DE 602004023620 T DE602004023620 T DE 602004023620T DE 602004023620 T DE602004023620 T DE 602004023620T DE 602004023620 D1 DE602004023620 D1 DE 602004023620D1
Authority
DE
Germany
Prior art keywords
cathepsin
present
provides compounds
methods
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004023620T
Other languages
English (en)
Inventor
Hong Liu
Arnab Chatterjee
David C Tully
Phillip B Alper
Badry Bursulaya
Jianhua Guo
David Woodmansee
Daniel Mutnick
Donald S Karanewsky
Yun He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IRM LLC
Original Assignee
IRM LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IRM LLC filed Critical IRM LLC
Publication of DE602004023620D1 publication Critical patent/DE602004023620D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
DE602004023620T 2003-08-20 2004-08-19 Inhibitoren von cathepsin s Active DE602004023620D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49698003P 2003-08-20 2003-08-20
US10/922,515 US7314872B2 (en) 2003-08-20 2004-08-18 Inhibitors of cathepsin S
PCT/US2004/026986 WO2005034848A2 (en) 2003-08-20 2004-08-19 Inhibitors of cathepsin s

Publications (1)

Publication Number Publication Date
DE602004023620D1 true DE602004023620D1 (de) 2009-11-26

Family

ID=34437256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004023620T Active DE602004023620D1 (de) 2003-08-20 2004-08-19 Inhibitoren von cathepsin s

Country Status (10)

Country Link
US (4) US7314872B2 (de)
EP (1) EP1658267B1 (de)
JP (1) JP2007502836A (de)
AT (1) ATE445598T1 (de)
AU (1) AU2004279331B2 (de)
BR (1) BRPI0413743A (de)
CA (1) CA2535930A1 (de)
DE (1) DE602004023620D1 (de)
MX (1) MXPA06001889A (de)
WO (1) WO2005034848A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101244185B1 (ko) * 2007-04-19 2013-03-25 유씬 리 정신 장애 치료용 신규 화합물, 그의 제조 방법 및 용도
US20090291945A1 (en) * 2008-04-09 2009-11-26 Teijin Pharma Limited Cysteine protease inhibitors
US20220193048A1 (en) 2019-04-05 2022-06-23 Universite De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3993795A (en) * 1994-12-02 1996-06-19 Fujisawa Pharmaceutical Co., Ltd. Peptide compounds for prevention and/or treatment of no-mediated diseases
US6504014B1 (en) 1997-05-19 2003-01-07 The John Hopkins University Tissue specific prodrug
AU8762798A (en) * 1997-08-11 1999-03-01 Warner-Lambert Company Aniline derivatives as calcium channel blockers
MXPA02001014A (es) * 1999-07-30 2002-08-12 Boehringer Ingelheim Pharma Nuevos compuestos derivados de succinato utiles como inhibidores de cisteina-proteasa.
ATE461290T1 (de) 2000-04-20 2010-04-15 Univ Georgia Verfahren zur identifizierung von aktivestellen- proteasinaktivatoren
JP2004256525A (ja) 2003-02-06 2004-09-16 Sankyo Co Ltd Ｎ−［１−置換−２−（アリールアミノ）エチル］アミド誘導体
US20070015485A1 (en) 2005-07-14 2007-01-18 Scosche Industries, Inc. Wireless Media Source for Communication with Devices on Data Bus of Vehicle

Also Published As

Publication number Publication date
US7314872B2 (en) 2008-01-01
AU2004279331B2 (en) 2007-08-30
EP1658267A2 (de) 2006-05-24
BRPI0413743A (pt) 2006-10-24
US20090137570A1 (en) 2009-05-28
JP2007502836A (ja) 2007-02-15
EP1658267A4 (de) 2007-08-01
MXPA06001889A (es) 2006-05-31
ATE445598T1 (de) 2009-10-15
US20100204200A1 (en) 2010-08-12
US20050113356A1 (en) 2005-05-26
WO2005034848A2 (en) 2005-04-21
WO2005034848A3 (en) 2005-10-27
US7501408B2 (en) 2009-03-10
US7732449B2 (en) 2010-06-08
AU2004279331A1 (en) 2005-04-21
CA2535930A1 (en) 2005-04-21
US20080108595A1 (en) 2008-05-08
EP1658267B1 (de) 2009-10-14

Similar Documents

Publication Publication Date Title
NO20044807L (no) Heratitt C virus inhibitorer
NO20062185L (no) Hepatitt C virus-inhibitorer
NO20070606L (no) Inhibitorer av IAP
NO20062339L (no) Hepatitt C virus-inhibitoerer
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
ATE433447T1 (de) Pyrimiidinverbindungen
NO20073783L (no) Pyrrolidininhibitorer for IAP
NO20062267L (no) Hepatitt C virus inhibitorer
TW200510317A (en) Caspase inhibitors and uses thereof
NO20083207L (no) Inhibitorer av IAP
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
NO20091707L (no) Inhibitorer av hepatitt C virus
NO20091704L (no) Inhibitorer av hepatitt C virus
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
RS94603A (en) Novel compounds and compositions as cathepsin inhibitors
TW200610522A (en) Substituted ethane-1,2-diamines for the treatment of alzheimer's disease
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition